Source: Eur Respir J 2015; 45: 449-462
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gomez-Arroyo Jose, Sakagami Masahiro, Syed Aamer A., Farkas Laszlo, Van Tassell Benjamin, Kraskauskas Donatas, Mizuno Shiro, Abbate Antonio, Bogaard Harm J., Byron Peter R., Voelkel Norbert F.. Iloprost reverses established fibrosis in experimental right ventricular failure. Eur Respir J 2015; 45: 449-462

Member's Comments

No comment yet.

Related content which might interest you: Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Right ventricular dysfunction in patients with pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Left and right ventricular function in patients with end-stage idiopathic pulmonary fibrosis. Which ventricle is most affected? Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 Right ventricular dysfunction and functional limitation in idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 31: 219-220 Year: 2008 Myocardial prostacyclin effects in experimental acute afterload-induced right ventricular failure Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Effects of epoprostenol infusion on myocardial inflammation in acute afterload-induced right ventricular failure Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Exercise training in progressive pulmonary hypertension induces right ventricular myocarditis Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Moderate exercise training in monocrotaline treated rats accelerates the progression towards right ventricular heart failure Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Right ventricular reserve in a piglet model of chronic pulmonary hypertension Source: Eur Respir J 2015; 45: 709-717 Year: 2015 Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017 The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001 Right and left ventricular dysfunction in patients with COPD and heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007